Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension
Sign Up to like & getrecommendations! Published in 2020 at "Liver International"
DOI: 10.1111/liv.14304
Abstract: The loss‐of‐function rs72613567 T > TA‐variant in the 17β‐hydroxysteroid dehydrogenase 13 (HSD17B13) gene might protect from alcoholic and non‐alcoholic fatty liver disease (ALD/NAFLD) and associated fibrosis/cirrhosis. We investigated the impact of the T > TA‐variant… read more here.
Keywords: hepatic decompensation; impact; decompensation mortality; rs72613567 ... See more keywords
Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease[S]
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Lipid Research"
DOI: 10.1194/jlr.p089953
Abstract: Hydroxysteroid 17-β dehydrogenase 13 (HSD17B13) is a lipid droplet-associated protein; its gene-encoding variants affect the chronic liver diseases, including nonalcoholic fatty liver disease (NAFLD). To estimate the effect of rs72613567, a splice variant with an… read more here.
Keywords: fatty liver; disease; liver; rs72613567 ... See more keywords